Aromatase inhibitor trials for Breast cancer

All Aromatase inhibitor trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Aromatase inhibitor for Breast cancer

• An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
  NCT07222267 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 31 locations
• Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）
  NCT06107673 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
  NCT07400523 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · 4 locations

Common questions

How many trials study Aromatase inhibitor for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.